Tasly Pharmaceutical Group Co., Ltd (SHA:600535)
14.25
-0.05 (-0.35%)
Mar 18, 2026, 3:00 PM CST
-6.74% (1Y)
| Market Cap | 21.29B -6.8% |
| Revenue (ttm) | 8.24B -3.1% |
| Net Income | 1.11B +15.7% |
| EPS | 0.74 +15.7% |
| Shares Out | 1.49B |
| PE Ratio | 19.26 |
| Forward PE | 12.18 |
| Dividend | 0.53 (3.71%) |
| Ex-Dividend Date | Oct 17, 2025 |
| Volume | 5,009,367 |
| Average Volume | 8,194,930 |
| Open | 14.30 |
| Previous Close | 14.30 |
| Day's Range | 14.17 - 14.32 |
| 52-Week Range | 13.75 - 17.69 |
| Beta | 0.42 |
| RSI | 41.30 |
| Earnings Date | Mar 20, 2026 |